Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

✍ Scribed by Kian Behbakht; Michael W. Sill; Kathleen M. Darcy; Stephen C. Rubin; Robert S. Mannel; Steven Waggoner; Russell J. Schilder; Kathy Q. Cai; Andrew K. Godwin; R. Katherine Alpaugh

• Book ID: 113963293
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 763 KB
• Volume: 123
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2011.06.022